When there is low prevalence of a condition, but a non-zero false positive rate of a test, the false positives generated by universal testing can in fact be a net dis-benefit (worry, invasive further procedures, etc) to the patient population as a whole, regardless of cost. This is a well understood statistical phenomenon, and is carefully considered by healthcare systems when advising on testing.